Rjp van der Valk
GlaxoSmithKline
2 Papers
5 Citations
Rjp van der Valk is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: COPD & Combination therapy. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Blood eosinophil counts and treatment response in COPD: analyses of IMPACT
Steven Pascoe,Neil Barnes,Guy Brusselle,Chris Compton,G.J. Criner,Mark T. Dransfield,Dmg Halpin,MeiLan K. Han,Benjamin Hartley,Emma Hilton,Peter Lange,Sally Lettis,David A. Lipson,David A. Lomas,Fernando J. Martinez,Alberto Papi,Nicolas Roche,Rjp van der Valk,Robert A. Wise,Dave Singh +19 more
5
Blood eosinophils and treatment response with triple and dual combination therapy in COPD: analysis of the IMPACT trial
Steven Pascoe,Neil Barnes,Guy Brusselle,Chris Compton,G.J. Criner,Mark T. Dransfield,Dmg Halpin,MeiLan K. Han,Benjamin Hartley,Peter Lange,Sally Lettis,David A. Lipson,David A. Lomas,Fernando J. Martinez,Alberto Papi,Nicolas Roche,Rjp van der Valk,Robert A. Wise,D. Singh +18 more
- 27 Jun 2019
3